The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Burden of Fibromyalgia and Comparisons With Osteoarthritis in the Workforce
Abstract
OBJECTIVES: To calculate the fibromyalgia (FM) burden of illness (BOI) from the employer perspective and to compare annual prevalence, work output, absence, and health benefit costs of employees with FM versus osteoarthritis (OA). METHODS: Retrospective regression model analysis comparing objective work output, total health benefit (health care, prescription drug, sick leave, disability, workers' compensation) costs, and absence days for FM, versus OA and NoFM cohorts, while controlling for differences in patient characteristics. RESULTS: FM prevalence was 0.73%; OA 0.90%. Total health benefit costs for FM were $8452 versus $11,253 (P < 0.0001) for OA and $4013 (P < 0.0001) for NoFM, with BOI = $4439. Total absence days were 16.8 versus 19.8 (P < 0.0001) and 6.4 (P < 0.0001), respectively. FM had significantly lower annual work output than NoFM (19.5%, P = 0.003) but comparable with OA. CONCLUSION: FM places a significant cost, absence, and productivity burden on employers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Wolfe, F., Ross, K., Anderson, J., Russell, I. J., & Hebert, L. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380104 · Cited by 2,416
Lost productive time and cost due to common pain conditions in the US workforce
Stewart, W. F. (2003) · JAMA · doi:10.1001/jama.290.18.2443 · Cited by 1,570
Patient perspectives on the impact of fibromyalgia
Arnold, L. M., Crofford, L. J., Mease, P. J., Burgess, S. M., Palmer, S. C., Abetz, L., & Martin, S. A. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.06.005 · Cited by 490
Modeling risk using generalized linear models
Blough, D. K., Madden, C. W., & Hornbrook, M. C. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00032-0 · Cited by 440
Comorbidity of Fibromyalgia and Psychiatric Disorders
Arnold, L. M., Hudson, J. I., Keck, P. E., Auchenbach, M. B., Javaras, K. N., & Hess, E. V. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0807 · Cited by 382
A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia
Wolfe, F., Anderson, J., Harkness, D., Bennett, R. M., Caro, X. J., Goldenberg, D. L., Russell, I. J., & Yunus, M. B. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400904 · Cited by 378
Berger, A., Dukes, E., Martin, S., Edelsberg, J., & Oster, G. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01480.x · Cited by 338
Weir, P. T., Harlan, G. A., Nkoy, F. L., Jones, S. S., Hegmann, K. T., Gren, L. H., & Lyon, J. L. (2006) · JCR: Journal of Clinical Rheumatology · doi:10.1097/01.rhu.0000221817.46231.18 · Cited by 322
Wolfe, F., & Michaud, K. D. (2004) · PubMed · Cited by 262
Cited by
Socio-economic costs of osteoarthritis: A systematic review of cost-of-illness studies
Puig-Junoy, J., & Ruiz Zamora, A. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2014.10.012 · Cited by 247
Economic and Humanistic Burden of Osteoarthritis: A Systematic Review of Large Sample Studies
Xie, F., Kovic, B., Jin, X., He, X., Wang, M., & Silvestre, C. (2016) · PharmacoEconomics · doi:10.1007/s40273-016-0424-x · Cited by 202
“The indirect costs associated with disability were close among the four claims data-based studies that used the actual employer’s payment for short- or long-term disability [14, 20, 23, 24].”
BackgroundMethodInfluentialFibromyalgia: An Afferent Processing Disorder Leading to a Complex Pain Generalized Syndrome
Smith, H. (2011) · Pain Physician · doi:10.36076/ppj.2011/14/e217 · Cited by 179
McDonald, M., DiBonaventura, M. D., & Ullman, S. (2011) · Journal of Occupational & Environmental Medicine · doi:10.1097/jom.0b013e318222af81 · Cited by 169
DiBonaventura, M., Gupta, S., McDonald, M., & Sadosky, A. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-83 · Cited by 159
“OA is associated with substantial reductions in productivity among employed individuals [13-15].”
BackgroundResultGore, M. R., Tai, K.-S., Sadosky, A., LESLIE, D. L., & Stacey, B. R. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.594347 · Cited by 141
Marlow, N. M., Bonilha, H. S., & Short, E. B. (2012) · Pain Practice · doi:10.1111/j.1533-2500.2012.00562.x · Cited by 131
Fibromyalgia-related costs and loss of productivity: a substantial societal burden
Lacasse, A., Bourgault, P., & Choinière, M. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1027-6 · Cited by 114
“Many other studies found a heavier economic burden of FMS compared with other disorders or healthy subjects [17, 19, 20, 23, 26, 28, 29, 31, 34, 35] while others studies have not found significant differences [18, 33, 36].”
DiBonaventura, M., Gupta, S., McDonald, M., Sadosky, A., Pettitt, D., & Silverman, S. L. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-30 · Cited by 106
“While several studies evaluated OA-related absenteeism [8-10,18], few data exist on presenteeism, despite presenteeism being suggested as the primary source of lost productivity in the general arthritis population [13,16,17,38].”
BackgroundResultSelf-citationFibromyalgia: an afferent processing disorder leading to a complex pain generalized syndrome.
Smith, H. S., Harris, R. E., & Clauw, D. J. (2011) · PubMed · Cited by 88
Work Ability in Fibromyalgia: An Update in the 21st Century
Palstam, A., & Mannerkorpi, K. (2017) · Current Rheumatology Reviews · doi:10.2174/1573397113666170502152955 · Cited by 64
“When comparing costs for productivity loss and health benefits between employees with FM and employees with osteoarthritis from the employer perspective, authors found that FM and osteoarthritis pose similar burdens of costs productivity loss and health benefits on employers [58].”
BackgroundBehandlung und Krankheitskosten des Fibromyalgiesyndroms in Deutschland
Marschall, U., Arnold, B., & Häuser, W. (2011) · Der Schmerz · doi:10.1007/s00482-011-1079-3 · Cited by 51
Galvez-Sánchez, C. M., Montoro, C. I., Moreno-Padilla, M., Reyes del Paso, G. A., & de la Coba, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10122706 · Cited by 45
Factors promoting sustainable work in women with fibromyalgia
Palstam, A., Gard, G., & Mannerkorpi, K. (2013) · Disability and Rehabilitation · doi:10.3109/09638288.2012.748842 · Cited by 43
Sanchez, R. J., Uribe, C., Li, H., Alvir, J. M., Deminski, M. C., Chandran, A., & Palacio, A. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.550605 · Cited by 45
Direct and Indirect Economic Costs Among Private-Sector Employees With Osteoarthritis
Berger, A., Hartrick, C. T., Edelsberg, J., Sadosky, A., & Oster, G. (2011) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3182337620 · Cited by 44
Clinical Overview of Fibromyalgia
McCarberg, B. H. (2011) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3181ff7bee · Cited by 38
Characteristics of suitable work from the perspective of patients with fibromyalgia
Bossema, E. R., Kool, M. B., Cornet, D., Vermaas, P., de Jong, M., van Middendorp, H., & Geenen, R. (2012) · Rheumatology · doi:10.1093/rheumatology/ker312 · Cited by 30
The Problem of Absenteeism and Presenteeism in the Workplace
Howard, K. J., Howard, J. T., & Smyth, A. F. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4839-6_8 · Cited by 32
Palstam, A., Larsson, A., Bjersing, J., Löfgren, M., Ernberg, M., Bileviciute-Ljungar, I., Ghafouri, B., Sjörs, A., Larsson, B., Gerdle, B., et al. (2014) · Journal of Rehabilitation Medicine · doi:10.2340/16501977-1843 · Cited by 27
Glasofer, A., & Dingley, C. (2021) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-021-01142-0 · Cited by 31
Gore, M. R., Tai, K.-S., Chandran, A., Zlateva, G., & LESLIE, D. L. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.629262 · Cited by 25
Marlow, N. M., Simpson, K. N., Vaughn, I. A., Jo, A., Zoller, J. S., & Short, E. B. (2017) · Pain Practice · doi:10.1111/papr.12585 · Cited by 26
“Short-acting opioids (SAOs) 83 (63) 387 (54) 148 (54) 406 (61) 69 (69) 1,093 (58) Long-acting opioids (LAOs) 7 (5) 27 (4) 9 (3) 19 (3) 6 (6) 68 (4) Other anticonvulsants: 1st generation 2 (2) 6 (< 1) 1 (< 1) 14 (2) 3 (3) 26 (1) Other anticonvulsants: 2nd generation 36 (27) 76 (11) 27 (10) 119 (18) 19 (19) 277 (15) Tri…”
Fibromyalgia Syndrome in Chronic Disabling Occupational Musculoskeletal Disorders
Howard, K. J., Mayer, T. G., Neblett, R., Perez, Y., Cohen, H. M., & Gatchel, R. J. (2010) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0b013e3181fc838d · Cited by 25
Axelsson, E., Hedman-Lagerlöf, M., Hedman-Lagerlöf, E., Ljótsson, B., & Andersson, E. (2020) · Psychosomatics · doi:10.1016/j.psym.2020.01.012 · Cited by 23
Giraldes, A. L. A., Salomão, R., Leal, P. D. C., Brunialti, M. K. C., & Sakata, R. K. (2016) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.12904 · Cited by 21
Self-reported disability in women with fibromyalgia from a tertiary care center
Horta‐Baas, G., & Romero‐Figueroa, M. D. S. (2019) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-019-0086-4 · Cited by 25
Mukhida, K., Carroll, W., & Arseneault, R. (2020) · Canadian Journal of Pain · doi:10.1080/24740527.2020.1820858 · Cited by 19
Harnett, J., Margolis, J. M., Cao, Z., Fowler, R., Sanchez, R. J., Mardekian, J., & Silverman, S. L. (2010) · Pain Practice · doi:10.1111/j.1533-2500.2010.00440.x · Cited by 17
Self-citationArthroscopic debridement of the degenerative knee – Is there still a role?
Law, G. W., Lee, J. K., Soong, J., Lim, J. W. S., Zhang, K. T., & Tan, A. H. C. (2018) · Asia-Pacific Journal of Sports Medicine Arthroscopy Rehabilitation and Technology · doi:10.1016/j.asmart.2018.11.003 · Cited by 16
Kleinman, N. L., Sanchez, R. J., Lynch, W. D., Cappelleri, J. C., Beren, I. A., & Joshi, A. V. (2011) · Pain Practice · doi:10.1111/j.1533-2500.2011.00453.x · Cited by 15
“003).(12) In a study by Waylonis et al.”
BackgroundSelf-citationLo, T., Parkinson, L., Cunich, M. M., & Byles, J. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2015.1037833 · Cited by 15
“Gamma regression is selected to account for the positive skewness and heteroskedasticity usually found in cost data [13,14].”
BackgroundGore, M. R., Tai, K.-S., Chandran, A., Zlateva, G., & LESLIE, D. L. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.629263 · Cited by 18
Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United States
Beard, S. M., Roskell, N., Le, T., Zhao, Y. W., Coleman, A., Ang, D. C., & Lawson, K. (2011) · Journal of Medical Economics · doi:10.3111/13696998.2011.586389 · Cited by 17
Dyne, A. V., Moy, J. H., Wash, K., Thompson, L., Skow, T. L., Roesch, S. C., & Cronan, T. A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19063413 · Cited by 16
“Comparing these two chronic painful disorders has been suggested as a way to establish the reference point of the illness impact of both FM and OA [20].”
BackgroundFibromyalgia and Disability Adjudication: No Simple Solutions to a Complex Problem
Harth, M., & Nielson, W. R. (2014) · Pain Research and Management · doi:10.1155/2014/321307 · Cited by 13
Karayol, K. C., & Karayol, S. S. (2021) · Journal of Physical Therapy Science · doi:10.1589/jpts.33.40 · Cited by 13
Marschall, U., Arnold, B., & Häuser, W. (2011) · Der Schmerz · Cited by 12
Cost of arthritis: a systematic review of methodologies used for direct costs
Lo, T., Parkinson, L., Cunich, M. M., & Byles, J. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1126513 · Cited by 10
“[20] However, it was also possible that some regression analyses were over-controlling for the health variables especially when comorbidity was included as an adjusting variable in the regression models.[31,34,36,44,51] Over-controlling occurs when one regressor (e.”
BackgroundMethodInfluentialThe costs associated with sleep symptoms among patients with fibromyalgia
Wagner, J.-S., Chandran, A., DiBonaventura, M., & Cappelleri, J. C. (2013) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/erp.12.82 · Cited by 11
The effects of local cold application on fibromyalgia pain
Yilmaz, N., & Kıyak, E. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13078 · Cited by 10
Gaskin, D. J., Richard, P., & Walburn, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-48046-6_1 · Cited by 8
Moral Hazard and Benefits Consumption Capital in Program Overlap
Butler, R., & Gardner, H. H. (2011) · Foundations and Trends® in Microeconomics · doi:10.1561/0700000037 · Cited by 8
Lage-Hansen, P. R., Chrysidis, S., Amris, K., Fredslund-Andersen, S., Christensen, R., & Ellingsen, T. (2022) · Scandinavian Journal of Rheumatology · doi:10.1080/03009742.2022.2145703 · Cited by 9
The Epidemiology and Prevalence of Fibromyalgia (FMS)
Chen, J. L., & McKenzie-Brown, A. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-15820-4_1 · Cited by 8
Health Coverage and Its Relation to the Prevalence and Intensity of Symptomatic Knee Osteoarthritis
Clearfield, J. S., & Segal, N. A. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318224d8b8 · Cited by 6
“The total cost is even higher if productivity losses are included.(4,5) Aggregate annual medical care expenditures in the United States on OA are estimated at $185.”
BackgroundStussman, B. J., Nahin, R. L., & Čeko, M. (2018) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2018-0085 · Cited by 6
“Furthermore, there are substantial health care costs associated with FM including hospitalization [5], work loss [6, 7], and direct medical costs [8, 9].”
BackgroundD'Souza, R. S., Klasová, J., Morsi, M., Vincent, A., Mohabbat, A. B., Whitfield, S., Radlicz, C. M., Sheen, S., Wang, D., Zhitnitsky, M. D., et al. (2026) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000008098 · Cited by 12
Calf Muscle Pump Stimulation as a Means to Reduce Symptoms of Fibromyalgia Syndrome
Baniak, L. M., Pierce, C. S., Hiester, E. D., & McLeod, K. J. (2014) · Biological Research For Nursing · doi:10.1177/1099800414546893 · Cited by 3
“Moreover, working adults with FM had an average of 17 days of missed work per year, as compared to 6 days for individuals without FM (Kleinman et al., 2009).”
BackgroundCappelleri, J. C., Bushmakin, A. G., Zlateva, G., & Chandran, A. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.727930 · Cited by 3
Sun, P., Peng, X., Novick, D., Andrews, J., & Sun, S. (2014) · Journal of Pain Research · doi:10.2147/jpr.s51636 · Cited by 3
Chronic Widespread Pain and Fibromyalgia Syndrome
Okifuji, A., & Hare, B. D. (2014) · Handbooks in health, work, and disability · doi:10.1007/978-1-4939-0612-3_6 · Cited by 2
Segal, B. M., & Mueller, B. A. (2011) · International Journal of Clinical Rheumatology · doi:10.2217/ijr.10.99 · Cited by 2
Fibromyalgia syndrome: considerations for dental hygienists.
Walters, A. W., Tolle, S. L., & McCombs, G. B. (2015) · PubMed · Cited by 3
Eficacia de las perfusiones de lidocaína en la fibromialgia
Verd, M., Leclerc, H. R., Perelló, C. S., Tutor, M. J. D. V., & Taberner, M. M. T. (2020) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2020.3796/2020 · Cited by 3
Hamilton, J. C., Martin, R. C., Stone, J., & Sherwood, I. M. (2018) · Cambridge University Press eBooks · doi:10.1017/9781316275450.004 · Cited by 2
A 6-year trend of the healthcare costs of arthritis in a population-based cohort of older women
Lo, T., Parkinson, L., Cunich, M. M., & Byles, J. (2015) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.2016.1096199 · Cited by 1
“Healthcare costs can be very different in individuals with different forms of arthritis, such as osteoarthritis and rheumatoid arthritis [11,13,33].”
BackgroundEvaluación de la función sexual en mujeres y hombres con fibromialgia
Rico‐Villademoros, F. (2014) · Institutional Repository of the University of Granada (University of Granada) · Cited by 2
Cursing the Darkness: Reactions to Fibromyalgia
Harth, M. (2013) · Pain Research and Management · doi:10.1155/2013/845076
“Kleinman et al (7) reported data obtained from approximately 700,000 employees from various large self-insured employers in the United States; employees with fibromyalgia incurred significantly higher total health benefit costs, and had a much higher number of days absent from work than employees without fibromyalgia;…”
BackgroundDerh, M. S. E., Shabaan, S. E., Abdelaziz, S. S., & Hashim, R. M. (2025) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2025.100462
Stevens, M., Locock, L., Doebl, S., Skea, Z. C., Dulake, D., Macfarlane, G. J., & Hollick, R. J. (2025) · SSM - Qualitative Research in Health · doi:10.1016/j.ssmqr.2025.100577 · Cited by 1
Sickness Absence Duration Across Twenty Different Pathologies: A Systematic Review
Mouton, L., Lambreghts, C., & Godderis, L. (2026) · Journal of Occupational Rehabilitation · doi:10.1007/s10926-026-10370-2
Metadata
- Authors
- Kleinman, N., Harnett, J., Melkonian, A., Lynch, W., Kaplan-Machlis, B., & Silverman, S. L.
- Corresponding author
- Kleinman, Nathan
- Venue
- Journal of Occupational & Environmental Medicine
- Published
- 2009-12
- Volume
- 51
- Issue
- 12
- Pages
- 1384-1393
- ISSN
- 1076-2752 (ISSN-L)
- OpenAlex
- W1966139644
- Cited by
- 62
- References
- 42
- Citations by year
- 2026: 2 · 2025: 2 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 3 · 2017: 4 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 3 · 2012: 4
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Occupational and Environmental Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- fibromyalgia, osteoarthritis, disease burden, employer costs, sick leave, absenteeism, labor productivity, disability, workers' compensation, prevalence, chronic pain
- MeSH terms
- Absenteeism, Adult, Female, Fibromyalgia, Humans, Male, Middle Aged, Osteoarthritis, Regression Analysis, United States, Prevalence, Databases, Factual, Health Care Costs, Workplace, Cost of Illness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.